HEADER OXIDOREDUCTASE 19-DEC-03 1RY0 TITLE STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AKR1C3, TRANS-1,2-DIHYDROBENZENE-1,2-DIOL DEHYDROGENASE, COMPND 5 CHLORDECONE REDUCTASE HOMOLOG HAKRB, HA1753, DIHYDRODIOL COMPND 6 DEHYDROGENASE, TYPE I, DIHYDRODIOL DEHYDROGENASE 3, DD3, 3-ALPHA- COMPND 7 HYDROXYSTEROID DEHYDROGENASE, 3ALPHA-HSD, PROSTAGLANDIN F SYNTHASE; COMPND 8 EC: 1.1.1.-, 1.3.1.20, 1.1.1.188; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1C3, DDH1, PGFS, KIAA0119; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROSTAGLANDIN F SYNTHASE, AKR1C3, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.KOMOTO,T.YAMADA,K.WATANABE,F.TAKUSAGAWA REVDAT 4 23-AUG-23 1RY0 1 REMARK REVDAT 3 11-OCT-17 1RY0 1 REMARK REVDAT 2 24-FEB-09 1RY0 1 VERSN REVDAT 1 02-NOV-04 1RY0 0 JRNL AUTH J.KOMOTO,T.YAMADA,K.WATANABE,F.TAKUSAGAWA JRNL TITL CRYSTAL STRUCTURE OF HUMAN PROSTAGLANDIN F SYNTHASE JRNL TITL 2 (AKR1C3). JRNL REF BIOCHEMISTRY V. 43 2188 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14979715 JRNL DOI 10.1021/BI036046X REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 73648 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 7365 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5126 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 384 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.060 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RY0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JAN-04. REMARK 100 THE DEPOSITION ID IS D_1000021133. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 5 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.02 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SOFTWARE AT APS 19BM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74430 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 3-ALPHA-HSD (PDB CODE: 1AFS) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, PH 6, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 MET B 1 REMARK 465 ASP B 2 REMARK 465 SER B 3 REMARK 465 LYS B 4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 6 159.66 178.86 REMARK 500 ASP A 132 -164.08 -79.70 REMARK 500 PHE A 197 70.55 -171.73 REMARK 500 SER A 221 169.87 72.32 REMARK 500 LYS A 225 -7.93 -56.34 REMARK 500 ARG A 250 -148.34 -119.95 REMARK 500 ASN B 11 2.75 -68.72 REMARK 500 ASN B 57 11.60 -150.29 REMARK 500 SER B 87 -6.91 -57.80 REMARK 500 ASP B 132 -173.60 -67.22 REMARK 500 PHE B 197 66.13 -162.77 REMARK 500 SER B 221 163.40 71.97 REMARK 500 LYS B 225 -9.11 -57.22 REMARK 500 TRP B 227 -81.56 -125.84 REMARK 500 ARG B 250 -151.71 -127.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 2324 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG2 A 2325 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 3324 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG2 B 3325 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RY8 RELATED DB: PDB REMARK 900 PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN DBREF 1RY0 A 1 323 UNP P42330 AK1C3_HUMAN 1 323 DBREF 1RY0 B 1 323 UNP P42330 AK1C3_HUMAN 1 323 SEQRES 1 A 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 A 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 A 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 A 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 A 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 A 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 A 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 A 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR SEQRES 1 B 323 MET ASP SER LYS GLN GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 B 323 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 B 323 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 B 323 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 B 323 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 B 323 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 B 323 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 B 323 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 B 323 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 B 323 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 B 323 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 B 323 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 B 323 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 B 323 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 B 323 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 B 323 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 B 323 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 B 323 GLN ARG ASP LYS ARG TRP VAL ASP PRO ASN SER PRO VAL SEQRES 19 B 323 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 B 323 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 B 323 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 B 323 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 B 323 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 B 323 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 B 323 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR HET NAP A2324 48 HET PG2 A2325 25 HET NAP B3324 48 HET PG2 B3325 25 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM PG2 PROSTAGLANDIN D2 HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN PG2 (5E,13E)-9,15-DIHYDROXY-11-OXOPROSTA-5,13-DIEN-1-OIC HETSYN 2 PG2 ACID FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 PG2 2(C20 H32 O5) FORMUL 7 HOH *384(H2 O) HELIX 1 1 PRO A 30 GLY A 45 1 16 HELIX 2 2 ALA A 52 ASN A 56 5 5 HELIX 3 3 ASN A 57 ASP A 71 1 15 HELIX 4 4 LYS A 75 ILE A 79 5 5 HELIX 5 5 TRP A 86 HIS A 90 5 5 HELIX 6 6 ARG A 91 GLU A 93 5 3 HELIX 7 7 LEU A 94 GLN A 107 1 14 HELIX 8 8 ASP A 143 ALA A 157 1 15 HELIX 9 9 ASN A 169 ASN A 178 1 10 HELIX 10 10 ARG A 199 LYS A 209 1 11 HELIX 11 11 VAL A 234 GLU A 237 5 4 HELIX 12 12 ASP A 238 LYS A 249 1 12 HELIX 13 13 THR A 251 ARG A 263 1 13 HELIX 14 14 ASN A 273 VAL A 281 1 9 HELIX 15 15 GLN A 282 GLU A 285 5 4 HELIX 16 16 THR A 289 GLY A 298 1 10 HELIX 17 17 SER A 308 ALA A 312 5 5 HELIX 18 18 TYR A 317 ASP A 321 5 5 HELIX 19 19 ARG B 31 GLY B 45 1 15 HELIX 20 20 ALA B 52 ASN B 56 5 5 HELIX 21 21 ASN B 57 ASP B 71 1 15 HELIX 22 22 LYS B 75 ILE B 79 5 5 HELIX 23 23 TRP B 86 HIS B 90 5 5 HELIX 24 24 ARG B 91 GLU B 93 5 3 HELIX 25 25 LEU B 94 GLN B 107 1 14 HELIX 26 26 ASP B 143 ALA B 157 1 15 HELIX 27 27 ASN B 169 ASN B 178 1 10 HELIX 28 28 ARG B 199 LYS B 209 1 11 HELIX 29 29 VAL B 234 GLU B 237 5 4 HELIX 30 30 ASP B 238 LYS B 249 1 12 HELIX 31 31 THR B 251 ARG B 263 1 13 HELIX 32 32 ASN B 273 VAL B 281 1 9 HELIX 33 33 GLN B 282 GLU B 285 5 4 HELIX 34 34 THR B 289 GLY B 298 1 10 HELIX 35 35 SER B 308 ALA B 312 5 5 HELIX 36 36 TYR B 317 ASP B 321 5 5 SHEET 1 A 2 CYS A 7 LYS A 9 0 SHEET 2 A 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 B 9 LEU A 19 GLY A 22 0 SHEET 2 B 9 HIS A 48 ASP A 50 1 O ASP A 50 N PHE A 21 SHEET 3 B 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49 SHEET 4 B 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 B 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 B 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165 SHEET 7 B 9 VAL A 212 TYR A 216 1 O VAL A 214 N VAL A 191 SHEET 8 B 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215 SHEET 9 B 9 LEU A 19 GLY A 22 1 N GLY A 20 O VAL A 267 SHEET 1 C 2 CYS B 7 LYS B 9 0 SHEET 2 C 2 PHE B 15 PRO B 17 -1 O MET B 16 N VAL B 8 SHEET 1 D 9 LEU B 19 GLY B 22 0 SHEET 2 D 9 HIS B 48 ASP B 50 1 O HIS B 48 N PHE B 21 SHEET 3 D 9 PHE B 80 LEU B 85 1 O PHE B 80 N ILE B 49 SHEET 4 D 9 VAL B 111 ILE B 116 1 O LEU B 115 N LEU B 85 SHEET 5 D 9 ALA B 160 SER B 166 1 O LYS B 161 N VAL B 111 SHEET 6 D 9 CYS B 188 GLU B 192 1 O CYS B 188 N VAL B 165 SHEET 7 D 9 VAL B 212 TYR B 216 1 O VAL B 214 N VAL B 191 SHEET 8 D 9 VAL B 266 LYS B 270 1 O VAL B 266 N ALA B 215 SHEET 9 D 9 LEU B 19 GLY B 22 1 N GLY B 20 O VAL B 267 SITE 1 AC1 34 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC1 34 TYR A 55 LYS A 84 HIS A 117 SER A 166 SITE 3 AC1 34 ASN A 167 GLN A 190 TYR A 216 SER A 217 SITE 4 AC1 34 ALA A 218 LEU A 219 SER A 221 GLN A 222 SITE 5 AC1 34 LEU A 236 ALA A 253 LEU A 268 ALA A 269 SITE 6 AC1 34 LYS A 270 SER A 271 TYR A 272 ARG A 276 SITE 7 AC1 34 GLN A 279 ASN A 280 HOH A1001 HOH A1039 SITE 8 AC1 34 HOH A1094 HOH A1096 HOH A1174 HOH A1180 SITE 9 AC1 34 HOH A1311 PG2 A2325 SITE 1 AC2 13 TYR A 24 LEU A 54 TYR A 55 TRP A 86 SITE 2 AC2 13 HIS A 117 MET A 120 LEU A 128 SER A 129 SITE 3 AC2 13 ASN A 167 PHE A 306 SER A 308 TYR A 319 SITE 4 AC2 13 NAP A2324 SITE 1 AC3 30 GLY B 22 THR B 23 TYR B 24 ASP B 50 SITE 2 AC3 30 TYR B 55 LYS B 84 HIS B 117 SER B 166 SITE 3 AC3 30 ASN B 167 GLN B 190 TYR B 216 SER B 217 SITE 4 AC3 30 LEU B 219 SER B 221 GLN B 222 ALA B 253 SITE 5 AC3 30 LEU B 268 ALA B 269 LYS B 270 SER B 271 SITE 6 AC3 30 TYR B 272 ASN B 273 ARG B 276 GLN B 279 SITE 7 AC3 30 ASN B 280 HOH B1025 HOH B1055 HOH B1193 SITE 8 AC3 30 HOH B1274 PG2 B3325 SITE 1 AC4 13 TYR B 24 LEU B 54 TYR B 55 TRP B 86 SITE 2 AC4 13 HIS B 117 SER B 129 ASN B 167 TRP B 227 SITE 3 AC4 13 PHE B 306 SER B 308 PHE B 311 TYR B 319 SITE 4 AC4 13 NAP B3324 CRYST1 46.970 49.180 83.520 73.80 85.90 69.80 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021290 -0.007833 0.000625 0.00000 SCALE2 0.000000 0.021666 -0.006116 0.00000 SCALE3 0.000000 0.000000 0.012473 0.00000